Correction to: BMC Med
https://doi.org/10.1186/s12916-019-1257-1
The original article [1] contained two minor errors:
-
1)
Author, Chee H. Ng’s middle initial was omitted;
-
2)
The Competing Interests declaration omitted some information regarding author, Chee H. Ng.
These two errors have since been corrected.
Reference
Berk M, et al. A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo. BMC Med. 2019;17:18 https://doi.org/10.1186/s12916-019-1257-1.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Berk, M., Turner, A., Malhi, G.S. et al. Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo. BMC Med 17, 35 (2019). https://doi.org/10.1186/s12916-019-1280-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12916-019-1280-2